دورية أكاديمية
أعرض في EDS

COMPARISON OF SOLIFENACIN VERSUS COMBINATION OF SOLIFENACIN AND TAMSULOSIN IN IMPROVING UNILATERAL DOUBLE-J STENT RELATED LOWER URINARY TRACT SYMPTOMS - A PROSPECTIVE RANDOMIZED CONTROL TRIAL

التفاصيل البيبلوغرافية
العنوان: COMPARISON OF SOLIFENACIN VERSUS COMBINATION OF SOLIFENACIN AND TAMSULOSIN IN IMPROVING UNILATERAL DOUBLE-J STENT RELATED LOWER URINARY TRACT SYMPTOMS - A PROSPECTIVE RANDOMIZED CONTROL TRIAL
المؤلفون: Muhammad Tanveer Sajid, Sami Ur Rehman, Muhammad Akmal, Hussain Ahmad, Zahoor Iqbal Mirza, Arshad Mahmood
المصدر: Pakistan Armed Forces Medical Journal, Vol 71, Iss 1, Pp 45-50 (2021)
بيانات النشر: Army Medical College Rawalpindi, 2021.
سنة النشر: 2021
المجموعة: LCC:Medicine
LCC:Medicine (General)
مصطلحات موضوعية: luts, solifenacin, ureteric stent-related symptoms, tamsulosin, ipss, Medicine, Medicine (General), R5-920
الوصف: Objective: To compare Solifenacin versus solifenacin plus tamsulosin in terms of international prostate symptom score (IPSS) for lower urinary tract symptoms (LUTS) in patients with unilateral double-J (DJ) ureteric stents. Study Design: Comparative cross sectional study. Place and Duration of Study: Armed Forces Institute of Urology, Rawalpindi from Sep 2018 to Feb 2019. Methodology: A total of two hundred (n=200) patients of either gender aged 20-50 years, who underwent unilateral DJ stenting for different endourological procedures, were enrolled after satisfying inclusion/exclusion criteria and then randomly allocated to group A (Solifenacin 5mg once daily (OD) ± placebo for 2 weeks) or group B (Solifenacin 5mg OD ± Tamsulosin 0.4 mg OD for 2 weeks) respectively. Baseline (1st post-operative day) and Post 02 weeks treatment IPSS was recorded and analyzed. Results: Mean age of presentation in group A and group B was 41.11 ± 6.45 vs 39.86 ± 5.34 years with p-value 0.14. Majority of patients in both groups were male (34% female in group A while 31% in group B, difference being statistically insignificant p 0.65). Baseline IPSS in group A and group B was 10.33 ± 2.72 vs 10.46 ± 3.12 with pvalue 0.76 (statistically insignificant) while post 02 weeks treatment IPSS in group A and B was 9.20 ± 2.67 vs 7.88 ± 2.63 respectively with p-value
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0030-9648
2411-8842
Relation: https://pafmj.org/index.php/PAFMJ/article/view/2617; https://doaj.org/toc/0030-9648; https://doaj.org/toc/2411-8842
DOI: 10.51253/pafmj.v71i1.2617
URL الوصول: https://doaj.org/article/8a1365e6cec04bcdbff60316cc2472e0
رقم الأكسشن: edsdoj.8a1365e6cec04bcdbff60316cc2472e0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00309648
24118842
DOI:10.51253/pafmj.v71i1.2617